JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Search

Quidel Corp

Fermé

11.89 -1.08

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.81

Max

12.23

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+71.68% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-483M

726M

Ouverture précédente

12.97

Clôture précédente

11.89

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 avr. 2026, 23:33 UTC

Résultats

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 avr. 2026, 22:40 UTC

Résultats

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 avr. 2026, 22:10 UTC

Acquisitions, Fusions, Rachats

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 avr. 2026, 21:11 UTC

Résultats

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 avr. 2026, 21:01 UTC

Résultats

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 avr. 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22 avr. 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 avr. 2026, 23:34 UTC

Market Talk
Principaux Événements d'Actualité

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 avr. 2026, 23:16 UTC

Résultats

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 avr. 2026, 23:15 UTC

Résultats

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 avr. 2026, 22:54 UTC

Résultats

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 avr. 2026, 22:54 UTC

Résultats

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 avr. 2026, 22:52 UTC

Résultats

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 avr. 2026, 22:51 UTC

Résultats

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 avr. 2026, 22:31 UTC

Résultats

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 avr. 2026, 22:31 UTC

Résultats

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 avr. 2026, 22:30 UTC

Résultats

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 avr. 2026, 22:30 UTC

Résultats

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 avr. 2026, 22:29 UTC

Résultats

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 avr. 2026, 22:28 UTC

Résultats

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 avr. 2026, 22:28 UTC

Résultats

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 avr. 2026, 22:27 UTC

Résultats

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 avr. 2026, 22:06 UTC

Market Talk
Résultats

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 avr. 2026, 21:55 UTC

Acquisitions, Fusions, Rachats

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 avr. 2026, 21:47 UTC

Résultats

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 avr. 2026, 21:37 UTC

Résultats

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 avr. 2026, 21:34 UTC

Résultats

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 avr. 2026, 21:29 UTC

Résultats

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 avr. 2026, 21:20 UTC

Market Talk
Résultats

Tesla Expands Manufacturing to Chips -- Market Talk

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

71.68% hausse

Prévisions sur 12 Mois

Moyen 20.67 USD  71.68%

Haut 30 USD

Bas 15 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat